Home » Topics » Regulatory

Regulatory
RSS

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

Harvard Scientific's liposomal prostaglandin E1 begins clinical trials

July 19, 1996

Alferon N injection undergoes phase III in HCV

July 19, 1996

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Athena Neurosciences acquires worldwide rights to new formulation of Carbatrol

July 19, 1996

Pharmos receives grant to develop loteprednol/tobramycin combination product

July 19, 1996

Zadaxin/zidovudine/interferon alpha combination enhances immune system

July 19, 1996

Triple anti-HIV therapy shows positive results

July 19, 1996

Protease inhibitor plus Epivir/Retrovir cocktail shows positive anti-HIV results

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...